Funded Tech Companies
VST BIO
Looking for the VC firms that provided funding to VST BIO? Coefficient Capital and private investors put venture money into this biopharmaceutical company.
Company Overview
Company Name
VST BIO
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Undisclosed
San Diego, CA Undisclosed
USA
San Diego, CA Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
VST BIO is a biotechnology company that develops antibodies for the treatment of inflammatory and cardiovascular diseases, including stroke and acute myocardial infarction, as well as sepsis. VST Bio utilizes this new class of therapeutics to control injury-induced inflammation and vascular permeability (and control edema formation) in acute stroke, and other acute cardiovascular disease, dramatically expanding the opportunities for effective medical therapy in stroke patients, in particular for the majority of patients who do not present within the first hours after onset of symptoms, and cannot be treated with conventional standard-of-care medical therapy.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
3/17/2026
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Krisztina Zsebo
Company Investors
Browse more funded tech companies:
Share this article
About Our VC Transaction Database
The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs